The COVID-19 vaccination acceptance/hesitancy rate and its determinants among healthcare workers of 91 Countries: A multicenter cross-sectional study.

COVID-19 COVID-19 vaccines HDI Human Development Index health personnel vaccination coverage

Journal

EXCLI journal
ISSN: 1611-2156
Titre abrégé: EXCLI J
Pays: Germany
ID NLM: 101299402

Informations de publication

Date de publication:
2022
Historique:
received: 22 10 2021
accepted: 15 12 2021
entrez: 28 2 2022
pubmed: 1 3 2022
medline: 1 3 2022
Statut: epublish

Résumé

The aim of this study was to investigate the COVID-19 vaccination acceptance rate and its determinants among healthcare workers in a multicenter study. This was a cross-sectional multi-center survey conducted from February 5 to April 29, 2021. The questionnaire consisted of 26 items in 6 subscales. The English version of the questionnaire was translated into seven languages and distributed through Google Forms using snowball sampling; a colleague in each country was responsible for the forward and backward translation, and also the distribution of the questionnaire. A forward stepwise logistic regression was utilized to explore the variables and questionnaire factors tied to the intention to COVID-19 vaccination. 4630 participants from 91 countries completed the questionnaire. According to the United Nations Development Program 2020, 43.6 % of participants were from low Human Development Index (HDI) regions, 48.3 % high and very high, and 8.1 % from medium. The overall vaccination hesitancy rate was 37 %. Three out of six factors of the questionnaire were significantly related to intention to the vaccination. While 'Perceived benefits of the COVID-19 vaccination' (OR: 3.82, p-value<0.001) and 'Prosocial norms' (OR: 5.18, p-value<0.001) were associated with vaccination acceptance, 'The vaccine safety/cost concerns' with OR: 3.52, p-value<0.001 was tied to vaccination hesitancy. Medical doctors and pharmacists were more willing to take the vaccine in comparison to others. Importantly, HDI with OR: 12.28, 95 % CI: 6.10-24.72 was a strong positive determinant of COVID-19 vaccination acceptance. This study highlighted the vaccination hesitancy rate of 37 % in our sample among HCWs. Increasing awareness regarding vaccination benefits, confronting the misinformation, and strengthening the prosocial norms would be the primary domains for maximizing the vaccination coverage. The study also showed that the HDI is strongly associated with the vaccination acceptance/hesitancy, in a way that those living in low HDI contexts are more hesitant to receive the vaccine.

Identifiants

pubmed: 35221837
doi: 10.17179/excli2021-4439
pii: 2021-4439
pmc: PMC8859647
doi:

Types de publication

Journal Article

Langues

eng

Pagination

93-103

Informations de copyright

Copyright © 2022 Askarian et al.

Références

Eur J Epidemiol. 2020 Aug;35(8):775-779
pubmed: 32785815
Nat Med. 2021 Aug;27(8):1385-1394
pubmed: 34272499
Vaccines (Basel). 2021 Feb 03;9(2):
pubmed: 33546165
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33097547
Expert Rev Vaccines. 2020 Oct;19(10):899-901
pubmed: 32945213
Nature. 2020 Dec;588(7836):16-18
pubmed: 33230278
Vaccines (Basel). 2021 Jul 22;9(8):
pubmed: 34451938
Lancet. 2021 Mar 13;397(10278):1023-1034
pubmed: 33587887
J Multidiscip Healthc. 2020 Nov 20;13:1657-1663
pubmed: 33262600
Pragmat Obs Res. 2020 Oct 29;11:103-109
pubmed: 33154695
Lancet. 2021 Jan 9;397(10269):72-74
pubmed: 33306990
EXCLI J. 2021 Mar 15;20:661-664
pubmed: 33883990
Nature. 2020 Nov;587(7834):337-338
pubmed: 33199901
N Engl J Med. 2020 May 21;382(21):1969-1973
pubmed: 32227757
Int J Infect Dis. 2021 Aug;109:286-293
pubmed: 34242765
J Health Commun. 2020 Oct 2;25(10):799-807
pubmed: 33719881
Int J Equity Health. 2021 Aug 14;20(1):183
pubmed: 34391416
Front Immunol. 2020 Oct 14;11:585354
pubmed: 33163000
J Cosmet Dermatol. 2019 Dec;18(6):1700-1704
pubmed: 30920111
Nature. 2020 Oct;586(7830):516-527
pubmed: 32967006

Auteurs

Mehrdad Askarian (M)

Department of Community Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran; Health Behavior Science Research Center, Shiraz University of Medical Sciences, Shiraz.

Aleksandr Semenov (A)

Ekaterinburg Research Institute of Viral Infections SRC VB Vector, Ekaterinburg, Russia.

Ferran Llopis (F)

Emergency Department. Bellvitge University Hospital, l'Hospitalet de Llobregat, Barcelona, Spain.

Francesca Rubulotta (F)

Department of Intensive Care Medicine, Charing Cross Hospital, Imperial College, NHS Trust London, UK.

Gorana Dragovac (G)

Department of Epidemiology, Faculty of Medicine, University of Novi Sad, Serbia; Center of Disease Prevention and Control, Institute of Public Health of Vojvodina, Novi Sad, Serbia.

Natalia Pshenichnaya (N)

Clinical Department of Infectious Pathology, Central Research Institute of Epidemiology, Moscow, Russia.

Ojan Assadian (O)

Regional Hospital Wiener Neustadt, Austria; Institute of Skin Integrity and Infection Prevention, University of Huddersfield, UK.

Yvon Ruch (Y)

Department of Infectious Diseases, Strasbourg University Hospital, Strasbourg, France.

Zahra Shayan (Z)

Trauma Research Center, Department of Biostatistics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Cristobal Padilla Fortunatti (C)

School of Nursing, Pontificia Universidad Catolica de Chile, Santiago, Chile.

Daniel Lucey (D)

Department of Infectious Diseases, Georgetown University Medical Center, Washington, DC 20057, USA.

Abdullah Almohaizeie (A)

King Faisal Specialist Hospital and Research Center, Riyadh, Alfaisal University Riyadh, Saudi Arabia.

Abu Hena Mostafa Kamal (AHM)

Department of Anaesthesiology & ICU, Rajshahi Medical College Hospital, Rajshahi, Bangladesh.

Adenike Ogunshe (A)

Applied Microbiology and Infectious Diseases, Department of Microbiology, Faculty of Science, University of Ibadan, Oyo State, Nigeria.

Aidos Konkayev (A)

Department of Anesthesiology and Intensive Care, Astana Medical University, Nur-Sultan, Kazakhstan; National Centre of Traumatology and Orthopedia named by Batpenov, Nur-Sultan, Kazakhstan.

Asim Beg (A)

Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan.

Enzo Primerano (E)

Department of Anesthesia and Intensive Care, Polyclinic of Monza, Monza, Italy.

Fatma Amer (F)

Department of Medical Microbiology and Immunology, School of Medicine, Zagazig University, Zagazig, Egypt.

Hema Prakash Kumari Pilli (HP)

Department of Microbiology, GITAM Institute of Medical Sciences and Research, GITAM , Deemed to be University, Visakhapatnam, India.

Ivan Hung (I)

Department of Infectious Diseases; Gastroenterology & Hepatology, The University of Hong Kong.

Folusakin Ayoade (F)

Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL 33136, USA.

Jean Yves Lefrant (JY)

Department of Anaesthesia, Critical Care Emergency and Pain Medicine, University Hospital of Nimes, Montpellier University, Nimes, France.

Joanna Zajkowska (J)

Department of Infectious Diseases and Neuroinfections, Medical University in Biaøystok, Poland.

Jordi Rello (J)

CRIPS, Vall Hebron Institute of Research (VHIR) & CHRU Nimes, Nimes, France.

Momin Kazi (M)

Research Department of Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan.

Mohammad Hossein Taghrir (MH)

Trauma Research Center, Shahid Rajaee (Emtiaz) Trauma Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.

Stijn Blot (S)

Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.

Stephen Leib (S)

Institute for Infectious Diseases, University of Bern, Bern, Switzerland.

Parisa Hosseinpour (P)

School of Medicine, Islamic Azad University, Kazeroun branch, Kazeroun, Iran.

Hamidreza Hosseinpour (H)

Department of Surgery, Shiraz Laparoscopic Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Amirhossein Erfani (A)

Thoracic and Vascular Surgery Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Roham Borazjani (R)

Trauma Research Center, Shahid Rajaee (Emtiaz) Trauma Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.

Hossein Akbarialiabad (H)

Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.

Masoud Najafi (M)

Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.

Ardalan Askarian (A)

Student, College of Arts & Science, University of Saskatchewan, Saskatoon, Canada.

Hakan Erdem (H)

ID-IRI Lead Coordinator, Ankara, Turkey.

Classifications MeSH